Header Logo

Connection

ABBAS RANA to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications ABBAS RANA has written about Liver Neoplasms.
ABBAS RANA
Connection Strength
2.570
Liver Neoplasms
  1. Disparate Intent-to-Treat Outcomes for Pediatric Liver Transplantation Based on Indication. Can J Gastroenterol Hepatol. 2023; 2023:2859384.
    View in: PubMed
    Score: 0.403
  2. Is Liver Transplant Justified at Any MELD Score? Transplantation. 2023 03 01; 107(3):680-692.
    View in: PubMed
    Score: 0.393
  3. Orthotopic liver transplantation in combination with neoadjuvant therapy: a new paradigm in the treatment of unresectable intrahepatic cholangiocarcinoma. Curr Opin Gastroenterol. 2012 May; 28(3):258-65.
    View in: PubMed
    Score: 0.190
  4. Retrospective Analysis of the Impact of High- and Low-Quality Donor Livers for Patients with?High-Acuity Illness. Ann Transplant. 2024 Jan 09; 29:e941931.
    View in: PubMed
    Score: 0.107
  5. Survival following liver transplantation for hepatocellular carcinoma after implementation of MMaT-3 policy. Liver Transpl. 2023 10 01; 29(10):1138-1142.
    View in: PubMed
    Score: 0.102
  6. Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium. Liver Transpl. 2023 07 01; 29(7):683-697.
    View in: PubMed
    Score: 0.101
  7. Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. Liver Transpl. 2023 01 01; 29(1):34-47.
    View in: PubMed
    Score: 0.099
  8. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era. Clin Gastroenterol Hepatol. 2023 08; 21(9):2288-2297.e4.
    View in: PubMed
    Score: 0.099
  9. Clinical Course and Outcomes of Patients with Nonalcoholic Fatty Liver Disease-Related Hepatocellular Cancer (NAFLD-HCC). Dig Dis Sci. 2023 03; 68(3):1060-1070.
    View in: PubMed
    Score: 0.096
  10. Posttransplant Outcomes in Older Patients With Hepatocellular Carcinoma Are Driven by Non-Hepatocellular Carcinoma Factors. Liver Transpl. 2021 05; 27(5):684-698.
    View in: PubMed
    Score: 0.088
  11. Liver Transplantation Outcomes in a U.S. Multicenter Cohort of 789 Patients With Hepatocellular Carcinoma Presenting Beyond Milan Criteria. Hepatology. 2020 12; 72(6):2014-2028.
    View in: PubMed
    Score: 0.086
  12. Liver transplant in a recently COVID-19 positive child with hepatoblastoma. Pediatr Transplant. 2021 08; 25(5):e13880.
    View in: PubMed
    Score: 0.086
  13. Pathologic Response to Pretransplant Locoregional Therapy is Predictive of Patient Outcome After Liver Transplantation for Hepatocellular Carcinoma: Analysis From the US Multicenter HCC Transplant Consortium. Ann Surg. 2020 04; 271(4):616-624.
    View in: PubMed
    Score: 0.082
  14. Impact of the Treating Hospital on Care Outcomes for Hepatocellular Carcinoma. Hepatology. 2018 11; 68(5):1879-1889.
    View in: PubMed
    Score: 0.074
  15. A long-term experience with expansion of Milan criteria for liver transplant recipients. Clin Transplant. 2018 06; 32(6):e13254.
    View in: PubMed
    Score: 0.072
  16. Fatal Central Nervous System Post-Transplant Lymphoproliferative Disease in a Patient Who Underwent Liver Transplantation for Hepatoblastoma. J Pediatr Gastroenterol Nutr. 2018 01; 66(1):e21-e23.
    View in: PubMed
    Score: 0.070
  17. Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation: Analysis of 3601 Patients From the US Multicenter HCC Transplant Consortium. Ann Surg. 2017 09; 266(3):525-535.
    View in: PubMed
    Score: 0.069
  18. Effects of an early referral system on liver transplantation for hepatoblastoma at Texas Children's Hospital. Pediatr Transplant. 2016 Jun; 20(4):515-22.
    View in: PubMed
    Score: 0.062
  19. Reply: To PMID 24954365. Hepatology. 2015 Oct; 62(4):1328-9.
    View in: PubMed
    Score: 0.059
  20. Reply: To PMID 24954365. Hepatology. 2015 Apr; 61(4):1439.
    View in: PubMed
    Score: 0.058
  21. Standing the test of time: outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment. Hepatology. 2014 Dec; 60(6):1957-62.
    View in: PubMed
    Score: 0.056
  22. A single-institution retrospective cases series of childhood undifferentiated embryonal liver sarcoma (UELS): success of combined therapy and the use of orthotopic liver transplant. J Pediatr Hematol Oncol. 2013 Aug; 35(6):451-5.
    View in: PubMed
    Score: 0.052
  23. Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg. 2009 Jul; 250(1):141-51.
    View in: PubMed
    Score: 0.039
  24. Cost of Care for Patients With Cirrhosis. Am J Gastroenterol. 2024 03 01; 119(3):497-504.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.